Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
CARDICA INC
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
CARDICA INC
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
CARDICA INC
SIC 3841 · Surgical & Medical Instruments & Apparatus
Notes
Support
about
terms
CARDICA INC
CIK:
0001178104
|
SEC Filings
Income Statement
v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Net revenue:
Product sales, net
$ 572,000
$ 427,000
License and development revenue
105,000
26,000
Royalty revenue
17,000
14,000
Total net revenue
694,000
467,000
Operating costs and expenses:
Cost of product sales
951,000
515,000
Research and development
1,748,000
1,768,000
Selling, general and administrative
1,824,000
2,019,000
Total operating costs and expenses
4,523,000
4,302,000
Loss from operations
(3,829,000)
(3,835,000)
Interest income
1,000
14,000
Interest expense
(150,000)
(133,000)
Other income (expense), net
441,000
(1,000)
Net loss
(3,537,000)
(3,955,000)
Deemed dividend attributable to convertible preferred stock
(101,000)
Net loss allocable to common stockholders
$ (3,638,000)
$ (3,955,000)
Basic net loss per share allocable to common stockholders (in dollars per share)
$ (0.09)
$ (0.44)
Diluted net loss per share allocable to common stockholders (in dollars per share)
$ (0.09)
$ (0.44)
Shares used in computing basic net loss per share allocable to common stockholders (in shares)
42,660
8,928
Shares used in computing diluted net loss per share allocable to common stockholders (in shares)
45,199
8,928